The best ASX growth shares to buy with $3,000 this month

Let's see why these growing stocks could be destined for big things in the future.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Aristocrat Leisure is transforming from a poker machine maker into a comprehensive entertainment entity, leveraging sales like its Plarium business to streamline focus on regulated online gaming and bolster expansion prospects.
  • ResMed stands out for its sustained growth potential within a vast market, embracing a robust recurring revenue model through its sleep and respiratory care products and platforms, poised to expand its global reach.
  • Temple & Webster offers a unique opportunity to invest in the trend towards ecommerce, with its adaptable and technology-driven approach helping it thrive despite the competitive retail landscape.

You don't need tens of thousands to start investing in great companies.

If you've got $3,000 to invest this month, spreading it across a few high-quality ASX growth shares could be a great way to build long-term wealth.

With that in mind, here are three standout ASX growth shares that analysts think could be worth considering in November. Here's what you need to know about them:

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.

Image source: Getty Images

Aristocrat Leisure Ltd (ASX: ALL)

Aristocrat Leisure is no longer just a poker machine maker, it has evolved into a global entertainment powerhouse operating across three major segments: Aristocrat Gaming, Aristocrat Interactive, and Product Madness. Together, these businesses serve millions of players daily across land-based casinos, free-to-play mobile games, and regulated real-money gaming.

The company recently announced the sale of its Plarium business for up to US$820 million, allowing it to streamline operations and focus on its core growth areas, especially the booming regulated online gaming sector. This move should strengthen the balance sheet and free up capital for expansion and new game development.

The team at Bell Potter believes that Aristocrat is well-placed for growth over the medium term. It recently put a buy rating and $79.00 price target on its shares.

ResMed Inc (ASX: RMD)

Another ASX growth share that analysts are bullish on is ResMed. It is a sleep and respiratory care leader that helps millions of people worldwide manage sleep apnoea and other chronic conditions with its range of connected devices and cloud-based software solutions.

The company's competitive advantage lies in its recurring revenue model, not just selling medical devices, but also generating ongoing income from mask and accessory sales, as well as digital patient monitoring platforms.

And with a total addressable market (TAM) estimated to be greater than 1 billion people, ResMed has a significant growth runway over the next decade and beyond.

The team at Macquarie is bullish on ResMed's outlook and has an outperform rating and $49.20 price target on its shares.

Temple & Webster Group Ltd (ASX: TPW)

For exposure to Australia's ecommerce growth, it is hard to look past Temple & Webster. The online furniture and homewares retailer continues to carve out a dominant position in a market that is steadily shifting away from traditional bricks-and-mortar retail.

The company has proven itself adaptable and innovative, investing heavily in AI-driven personalisation, home improvement products, and design technology to enhance the customer experience. Its scalable, capital-light business model has allowed it to maintain healthy margins even in a challenging consumer environment.

For investors looking to own a homegrown digital success story, Temple & Webster offers significant long-term potential.

Bell Potter recently upgraded its shares to a buy rating with a $28.00 price target.

Motley Fool contributor James Mickleboro has positions in ResMed and Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Temple & Webster Group. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Person using a calculator with four piles of coins, each getting higher, with trees on them.
Growth Shares

Experts rate these 2 ASX growth shares as buys this month!

These businesses have plenty of positives according to analysts.

Read more »

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Growth Shares

3 ASX shares being unfairly punished by the market selloff and could rise 100%

Analysts think these shares could rebound strongly after heavy declines.

Read more »

Two players on a field pump their fists in the air, indicating two of the best
Growth Shares

2 amazing ASX shares to buy for long-term growth

Both billion dollar stocks combine strong growth, scalability and a leadership position.

Read more »

A beautiful woman holds up one finger with one hand and has her hand on her waist with the other as she smiles widely as though she is very pleased about something.
Growth Shares

2 ASX 200 shares that now have 60% upside: Analysts

With markets under pressure, some ASX 200 shares are starting to look more interesting. Here are two that stand out…

Read more »

Man looking amazed holding $50 Australian notes, representing ASX dividends.
Growth Shares

Where to invest $10,000 in ASX shares right now

These quality shares could be worth considering. Let's find out why.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Growth Shares

$3k to invest? 2 ASX shares to consider buying in 2026

These shares have been sold off and could offer major upside according to analysts.

Read more »

One girl leapfrogs over her friend's back.
Growth Shares

This dirt cheap ASX retail stock is tipped to double in value

Better execution and easing pressures could spark a powerful rebound.

Read more »

A smiling man points upwards with both fingers in an exaggerated sideways pose.
Growth Shares

Buy these 2 top ASX 200 shares and hold until 2036

Brokers are tipping 50 to 150% upside from here.

Read more »